Abstract：Objective To study the application effect of PDCA cycle management in high risk patients with lower extremity venous thromboembolism (VTE). Methods A total of 97 high risk patients with lower extremity VTE admitted to Department of Radiology and Intervention in Foshan Hospital of Traditional Chinese Medicine from June 2018 to June 2019 were selected as the control group, and 92 high risk patients with lower extremity VTE from June 2020 to June 2021 were selected as the observation group. The control group received VTE routine care, the observation group received PDCA cycle management including planning stage, doing stage, checking stage and action stage. The incidence of thrombosis, length of hospital stay, in-hospital mortality, satisfaction with hospitalization and anxiety were recorded of the two groups. Results The incidence of deep venous thrombosis in the observation group was lower than that in the control group, and the length of hospital stay in the observation group was shorter than that in the control group, the difference was statistically significant (P<0.05). There were no significant differences in the incidence of pulmonary embolism and in-hospital mortality between the two groups (P>0.05). The total satisfaction with hospitalization of the observation group was higher than that of the control group, the difference was statistically significant (P<0.05). Before nursing, there was no significant difference in SAS scores between the two groups (P>0.05). After nursing, the SAS score of the two groups was lower than that before nursing, and the SAS score of the observation group was lower than that of the control group, the difference was statistically significant (P<0.05). Conclusion Compared with the routine nursing, the PDCA cycle management can effectively reduce the incidence of VTE in high risk patients with lower extremity deep vein thrombosis, shorten the length of hospital stay, and improve the satisfaction of patients with nursing care.
Nicholson M，Chan N，Bhagirath V，et al.Prevention of venous thromboembolism in 2020 and beyond[J].J Clin Med，2020，9（8）：2467.
[2]
Tritschler T，Kraaijpoel N，Le Gal G，et al.Venous thromboembolism：advances in diagnosis and treatment[J].JAMA，2018，320（15）：1583-1594.
[3]
Zhang L，Feng X，Zhang D，et al.Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan，China：prevalence，risk factors，and outcome[J].Circulation，2020，142（2）：114-128.
[4]
Trimaille A，Curtiaud A，Marchandot B，et al.Venous thromboembolism in non-critically ill patients with COVID-19 infection[J].Thromb Res，2020，193：166-169.
[5]
Voicu S，Bonnin P，Stépanian A，et al.High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients[J].J Am Coll Cardiol，2020，76（4）：480-482.
京公网安备 11010502046607号